These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8177328)

  • 1. Rhône-Poulenc to focus biotech work on gene therapy.
    Butler D
    Nature; 1994 May; 369(6476):92. PubMed ID: 8177328
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhône-Poulenc lifts Institut Mérieux stake.
    Ward M
    Nature; 1993 Oct; 365(6446):478. PubMed ID: 8413595
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy network sets industrial mould.
    Butler D
    Nature; 1994 Nov; 372(6503):210. PubMed ID: 7969457
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech pharmaceuticals and biotherapy: an overview.
    Steinberg FM; Raso J
    J Pharm Pharm Sci; 1998; 1(2):48-59. PubMed ID: 10945918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fallout from the merger that might be.
    Hodgson J
    Nat Biotechnol; 1999 Jan; 17(1):15-6. PubMed ID: 9920254
    [No Abstract]   [Full Text] [Related]  

  • 6. BIO 2006 Annual International Convention. The expanding biotech industry of France.
    Zarkowska T
    IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302
    [No Abstract]   [Full Text] [Related]  

  • 7. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
    Tear S; Zarkowska T
    IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
    Persidis A; Persidis A
    Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
    [No Abstract]   [Full Text] [Related]  

  • 9. France to focus on a few biotech clusters.
    Balcon E
    Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech round the world: focus on Chile.
    Biotechnol J; 2007 Jun; 2(6):667-8. PubMed ID: 17570697
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotech round the world: focus on Uganda.
    Biotechnol J; 2008 Aug; 3(8):986-7. PubMed ID: 18756621
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy: cursed or inching towards credibility?
    Branca MA
    Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
    [No Abstract]   [Full Text] [Related]  

  • 13. Darwin deal marks growth of link-ups for gene companies.
    Lehrman S
    Nature; 1994 Oct; 371(6498):546. PubMed ID: 7935772
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
    Gruber AC
    Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotechnology industry responds to gene therapy death.
    Commander H
    Nat Med; 2000 Feb; 6(2):118. PubMed ID: 10655080
    [No Abstract]   [Full Text] [Related]  

  • 16. Rhône-Poulenc: from bioscience to markets. The how, why, and when of the world's seventh-largest chemicals company.
    Ward M
    Biotechnology (N Y); 1993 Jul; 11(7):798-801. PubMed ID: 7763858
    [No Abstract]   [Full Text] [Related]  

  • 17. Boehringer networks to get ahead in gene therapy.
    Johnson E
    Nat Biotechnol; 1997 Jan; 15(1):12-3. PubMed ID: 9035095
    [No Abstract]   [Full Text] [Related]  

  • 18. Investing in oncology biotech stocks.
    Feuerstein A
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):879-80. PubMed ID: 18185485
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech round the world: focus on Canada.
    Biotechnol J; 2008 Jul; 3(7):848-51. PubMed ID: 18624341
    [No Abstract]   [Full Text] [Related]  

  • 20. Japanese firms broaden investment focus to early biotech.
    Louët S; Sipp D
    Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.